SINGAPORE -�Media OutReach�-�23�October 2019 -�MIMS
Group, Asia's largest multi-channel provider of drug information, medical communications, events
management and marketing services, and Ashfield Healthcare Communications KK,
announced they have combined operations in Japan. The newly established
organisation will be operating as MIMS Japan Co. Ltd.
�
MIMS and Ashfield Healthcare Communications formed a
strategic alliance in January 2019. The synergy between MIMS and Ashfield
Healthcare Communications will use local knowledge within country to execute
best in class and compliant regional and global programs at the local level. It
will provide clients with strengthened capabilities from both organisations
including Japanese and English medical communications and publications services
for the local Japan- market, APAC region wide scientific strategy and digital
healthcare expertise and global solutions.
�
MIMS Group, now under the umbrella of SMS Co. Ltd. (TYO
2175), has been offering diverse expertise for over 50 years in 17 countries
and markets in Asia, Oceana and the Middle East with a focus on providing marketing
support services to pharmaceutical companies, error detection system integrated
in healthcare institutions as well as services to empower healthcare professionals
in their daily operations. MIMS marketing platform services is spread across 10
countries mainly in South East Asia and has over 2.5 million healthcare
professionals registered on the mims.com website, with drug directory services,
medical communications, as well as media platform business. MIMS Japan Co.
Ltd., headed by CEO Yasunobu Sakai, was established in April 2017, offering
one-stop services in the Asia Pacific region to Japanese pharmaceutical
manufacturers, healthcare and food manufacturing companies
�
"The alliance with Ashfield Healthcare Communications enables
us to give a distinct benefit of delivering a global standard quality to our
Japanese clients, in addition to the one stop services for expanding in South
East Asia being offered by MIMS Japan Co. Ltd. " said Yasunobu Sakai, CEO of
MIMS Group.
�
Ashfield Healthcare Communications, part of UDG
Healthcare plc, provides global solutions for clients, adding value by
connecting scientific excellence, creativity and data capabilities to
flawlessly execute powerful, multichannel communication solutions. Ashfield
Healthcare Communications has a global network of 1,300 employees collaborating
with more than 100 pharma, biotech, device and nutraceutical companies.
�
Ashfield Healthcare Communications
Executive Director Richard Lawrence said: "Ashfield Healthcare Communications
already works with several Japanese pharmaceutical companies on a global basis.
Further strengthening our partnership with MIMs will enhance our ability to
better serve these companies regionally and in the Japan market."
�
Victor Wright, MIMS Chief Client
Officer for pharma marketing said, "As the largest medical communications
company in the APAC region outside of Japan and China, MIMS Group has the local
country expertise to help Japanese companies extend their programs and
communications throughout the APAC region."
�
For more information on MIMS, visit http://corporate.mims.com or www.mimsmc.com for medical communications services.
�
For Ashfield Healthcare Communications, visit www.ashfieldhealthcare.com
NOTES TO EDITOR
About MIMS
MIMS Group, now under the umbrella of SMS Co. Ltd. (TYO
2175), has been offering diverse expertise for over 50 years in 17 countries
and markets in Asia, Oceana and the Middle East with a focus on providing
marketing support services to pharmaceutical companies, error detection system
integrated in healthcare institutions as well as services to empower healthcare
professionals in their daily operations. MIMS marketing platform services is
spread across 10 countries mainly in South East Asia and has over 2.5 million
healthcare professionals registered on the mims.com website, with drug directory
services, medical communications, as well as media platform business. MIMS
Japan Co. Ltd., headed by CEO Yasunobu Sakai, was established in April 2017,
offering one-stop services in the Asia Pacific region to Japanese
pharmaceutical manufacturers, healthcare and food manufacturing companies
MIMS has offices in the following countries & regions:
Singapore (headquarters), Australia, China, Hong Kong SAR
(China), Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, New
Zealand, Philippines, Taiwan, Thailand, UAE, and Vietnam.
Visit http://corporate.mims.com�to learn more, and www.mimsmc.com�for medical communications services.
About Ashfield Healthcare Communications
Ashfield Healthcare Communications, part of UDG
Healthcare plc, provides global solutions for clients, adding value through
unique insights and tailored scientifically rigorous, multichannel, healthcare
communications offerings. Its mission is to improve lives by helping healthcare
professionals and patients get the medicines, knowledge, and support they need.
Ashfield Healthcare Communications' multichannel and specialist agencies
include ACUMED, Ashfield Digital & Creative, Ashfield Healthcare
Communications K.K., BlueMomentum, Cambridge BioMarketing, CircleScience,
Cirrus Communications, Clinical Bridges, CodonMedical, Create NYC, FireKite,
Galliard, Gardiner-Caldwell Communications, GeoMed, iMed Comms, Infusion,
MicroMass, Nyxeon, Pegasus, Physicians World Europe, QXV Comms, Scientific
Connexions, Seren Communications, StemScientific, Watermeadow Medical, and
Zoetic Science.
For more information, please go to www.ashfieldhealthcarecommunications.com.
About Ashfield
Ashfield, part of UDG Healthcare plc, is a global leader
in commercialisation services for the healthcare industry. We partner with our
clients across Advisory, Healthcare Communications, Commercial, Patient
Solutions and Medical Affairs to build creative, scalable and tailored health
solutions that are executed flawlessly, to deliver positive outcomes for
patients and add value to your business. With 7,000 employees, the company
operates in 25 countries, delivering services in more than 50 countries across
Europe, North America, South America and Asia. It works with more than 250
businesses, including all of the world's top 25 pharmaceutical companies.
Its mission is to partner with its
clients, helping to improve lives by ensuring healthcare professionals and
patients get the medicines, knowledge and support they need.
Ashfield provides contract sales
teams, customer service reps, medical science liaison officers, remote
detailing, nurse educators, medical information, healthcare communications,
market access, market research, training, live and virtual events, digital,
creative, pharmacovigilance, audit and advisory services.
For more information, go to www.ashfieldhealthcare.com.
